文献速递颈动脉与弓上血管

真实世界研究评价β受体阻滞剂使用与颈动脉内膜切除术后不良事件关联的系统综述与Meta分析

A systematic review and meta-analysis of real-world studies evaluating the association between beta-blocker use and postoperative adverse events of carotid endarterectomy.
PubMed 文献 · J Vasc Surg · 2021-11-14

该系统综述与Meta分析检索MEDLINE、EMBASE和CENTRAL至2021年4月,纳入7项观察性研究(6项病例对照研究、1项队列研究),评估术前β受体阻滞剂使用与颈动脉内膜切除术后不良事件的关联。基于随机效应模型的合并分析显示,β受体阻滞剂使用与复合术后不良事件显著相关(OR 1.35,95%CI 1.15-1.59,P=0.0003,I²=13%),与30天卒中或死亡无显著相关(OR 1.61,95%CI 0.98-2.65,P=0.06,I²=0%)。作者认为真实世界中β受体阻滞剂使用者颈动脉内膜切除术后不良结局风险增加。

要点

  • β受体阻滞剂使用与颈动脉内膜切除术后复合不良事件显著相关(OR 1.35,95%CI 1.15-1.59)。
  • β受体阻滞剂与30天卒中或死亡无显著相关(OR 1.61,95%CI 0.98-2.65,P=0.06)。
  • 一项队列研究报道β受体阻滞剂与术后心肌梗死相关(OR 1.96,95%CI 1.86-2.07)。

核心结论

  • 该系统综述提示,真实世界中β受体阻滞剂使用者较非使用者颈动脉内膜切除术后不良结局风险增加。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE和CENTRAL至2021年4月,纳入7项观察性研究(6项病例对照研究、1项队列研究),采用随机效应模型进行合并分析。

主要发现

  • 三项病例对照研究探讨β受体阻滞剂与复合术后不良事件的关联,其中两项研究包含三个数据集共24,161例参与者纳入定量合成,合并结果显示β受体阻滞剂使用与复合术后不良事件显著相关(OR 1.35,95%CI 1.15-1.59,P=0.0003,I²=13%)。
  • 两项纳入研究采用术中脑电图或术中血流动力学指标间接评估脑缺血,发现β受体阻滞剂与术中脑缺血显著相关。
  • 另两项研究纳入Meta分析评估β受体阻滞剂与颈动脉内膜切除术后30天卒中或死亡的关联(OR 1.61,95%CI 0.98-2.65,P=0.06,I²=0%)。
  • 仅一项队列研究通过χ²分析报道β受体阻滞剂与术后心肌梗死的关联(OR 1.96,95%CI 1.86-2.07)。
  • Meta分析未检测到发表偏倚(Egger检验P=0.453)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to estimate the association of beta-blocker use with postoperative adverse events of carotid endarterectomy (CEA) based on real-world data. METHODS: Electronic bibliographic sources (MEDLINE, EMBASE, and CENTRAL) were searched up to April 2021 using a combination of thesaurus and free-text terms to identify the studies about the effect of beta-blockers on outcomes of CEA. The systematic review was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. All observational studies and randomized controlled trials investigating the effect of preoperative beta-blockers on the outcomes of CEA were included. Independent extraction of articles by two authors using predefined data fields, including study quality indicators. All pooled analyses were based on a random-effects model. RESULTS: A total of seven observational studies (six case-control studies and one cohort study) were included. Of the three case-control studies that examined the association of beta-blockers with composite postoperative adverse events, two studies including three datasets that totaled 24,161 participants were included in the quantitative synthesis, and the overall results showed a statistically significant association between beta-blocker use and composite postoperative adverse events of CEA (odds ratio [OR], 1.35; 95% confidence interval [CI], 1.15-1.59; P = .0003; I2 = 13%). Publication bias was not present in the meta-analysis (Egger test showed nonsignificant results: P = .453). Two of the included studies utilized indirect measures of cerebral ischemia: intraoperative electroencephalograph, intraoperative hemodynamic indicators; and found a significant association between beta-blockers and intraoperative cerebral ischemia. Another two studies were included for meta-analysis on the association between beta-blockers and 30-day strokes or death of CEA (OR, 1.61; 95% CI, 0.98-2.65; P = .06; I2 = 0%). Of all included studies, there was only one cohort study that reported the association of beta-blockers with postoperative myocardial infarction by χ2 analysis (OR, 1.96; 95% CI, 1.86-2.07). CONCLUSIONS: This systematic review suggested that there was an increased risk of postoperative adverse outcomes of CEA among beta-blocker users compared with nonusers in the real world.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gao JP, Wu Y, Guo W, et al. A systematic review and meta-analysis of real-world studies evaluating the association between beta-blocker use and postoperative adverse events of carotid endarterectomy. J Vasc Surg. 2021. PMID: 34788650. doi:10.1016/j.jvs.2021.10.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。